NextCure, Inc.
NXTC
$12.32
$0.363.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.84M | -58.01M | -60.93M | -49.52M | -55.65M |
| Total Depreciation and Amortization | 2.19M | 2.49M | 2.66M | 2.73M | 2.87M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.09M | 3.93M | 4.56M | 5.39M | 7.45M |
| Change in Net Operating Assets | 954.00K | 2.64M | -426.00K | 207.00K | 4.53M |
| Cash from Operations | -49.61M | -48.94M | -54.13M | -41.19M | -40.81M |
| Capital Expenditure | -- | 34.00K | -136.00K | -437.00K | -474.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.56M | 26.48M | 36.25M | 44.96M | 55.78M |
| Cash from Investing | 25.56M | 26.51M | 36.12M | 44.52M | 55.31M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23.54M | 2.06M | 2.06M | 143.00K | 144.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.22M | -- | -- | -- | -- |
| Cash from Financing | 22.31M | 2.06M | 2.06M | 143.00K | 144.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.75M | -20.38M | -15.96M | 3.47M | 14.65M |